ATYR PHARMA INC (LIFE)
US0021202025 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to LIFE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 23.05. This target is 1340.75% above the current price.
LIFE was analyzed by 11 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about LIFE.
In the previous month the buy percentage consensus was at a similar level.
LIFE was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-15 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-03-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-21 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-07-05 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2023-05-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-10 | RBC Capital | Reiterate | Outperform |
| 2023-04-11 | Piper Sandler | Maintains | Overweight |
| 2023-03-10 | RBC Capital | Reiterate | Outperform |
| 2023-03-10 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-06 | Roth MKM | Reiterate | Buy |
| 2023-03-02 | RBC Capital | Maintains | Outperform |
| 2023-02-07 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-08-16 | Piper Sandler | Maintains | Overweight |
| 2022-07-21 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-18 | Piper Sandler | Maintains | Overweight |
| 2022-05-10 | RBC Capital | Maintains | Outperform |
| 2021-11-11 | HC Wainwright & Co. | Maintains | Buy |
| 2021-10-12 | RBC Capital | Initiate | Outperform |
| 2021-09-21 | Piper Sandler | Initiate | Overweight |
| 2021-09-14 | Oppenheimer | Maintains | Outperform |
| 2021-09-14 | Roth Capital | Maintains | Buy |
| 2021-09-13 | HC Wainwright & Co. | Maintains | Buy |
| 2021-05-18 | JonesTrading | Initiate | Buy |
| 2021-03-24 | Oppenheimer | Maintains | Outperform |
| 2021-03-16 | Roth Capital | Maintains | Buy |